4//SEC Filing
MEELIA RICHARD J 4
Accession 0001127602-21-004202
CIK 0000313143other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:51 PM ET
Size
8.8 KB
Accession
0001127602-21-004202
Insider Transaction Report
Form 4
MEELIA RICHARD J
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-04$35.50/sh+10,353$367,557→ 42,403 total - Sale
Common Stock
2021-02-04$134.64/sh−10,353$1,393,928→ 32,050 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2021-02-04−10,353→ 0 totalExercise: $35.50From: 2015-07-23Exp: 2021-07-23→ Common Stock (10,353 underlying)
Footnotes (4)
- [F1]The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.39 to $135.30, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Options vest 100% on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001223633
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:51 PM ET
- Size
- 8.8 KB